Public Relations
A New Role for Patient Advocates
Access to innovative new drugs is an issue that is hitting home for many ...
A New Age in Pricing
Medicines are the preferred path to arrest disease and restore health. And while scientists ...
Say Goodbye to FDA Complacency
Too many people think the Food and Drug Administration (FDA) favors predictability over speed. ...
Is it Invention or Innovation?
Words reflect intent. There was a time in the 1980s and early ’90s that ...
Product Launch Success: Bridging the Gap from Research to Real World
Product launch is in many ways the ultimate test for healthcare communicators: Will the ...
The Art of Indecision
Caution: We are entering a climate of uncertainty, where the natural response is a ...
Expanded Access Programs Require Compassionate Communications to Keep Your Reputation Intact
No company wants to be seen as uncaring, least of all in the healthcare ...
Off-label Guidance Finally Arrives
In January, the FDA released its long-anticipated draft guidance, regarding promotion of a medication’s ...
Live from Facebook! It’s Your Friendly Pharma Company
“Live.” It’s a word that can send a shudder through any pharma marketer, but ...
What I Learned from LISTENING to Reporters
Bernard M. Baruch, famed financier, political consultant, and philanthropist, once noted, “Most of the ...
Which Comes First: Trust or User Experience?
For anyone who has been a patient—or cared for one—finding trustworthy information online is ...
If Science Can Evolve, Why Can’t, or Isn’t, Pharma Marketing?
While new treatments focusing on personalized medicine, biosimilars, and targeting specific proteins have come ...
Media Firestorm Surrounds Oncology Communications
For decades now, the price of prescription drugs has been the subject of heated ...
